Alerts will be sent to your verified email
Verify Email
HIKAL
|
Hikal
|
Innova Captab
|
Shilpa Medicare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
4.0 % | n/a | 4.68 % |
|
Financials
|
|||
|
5 yr Average ROE
|
12.04 % | 25.66 % | 6.52 % |
|
5yr average Equity Multiplier
|
2.23 | 2.7 | 1.57 |
|
5yr Average Asset Turnover Ratio
|
0.84 | 1.32 | 0.4 |
|
5yr Avg Net Profit Margin
|
6.39 % | 7.35 % | 10.22 % |
|
Price to Book
|
3.27 | 6.96 | 3.02 |
|
P/E
|
52.23 | 39.85 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
44.89 Days | 40.02 Days | 113.38 Days |
|
Inventory Days
|
66.84 Days | 51.47 Days | 103.45 Days |
|
Days Receivable
|
79.34 Days | 92.58 Days | 123.51 Days |
|
Days Payable
|
84.24 Days | 104.38 Days | 118.45 Days |
|
5yr Average Interest Coverage Ratio
|
4.97 | 9.81 | 18.78 |
|
5yr Avg ROCE
|
15.64 % | 28.46 % | 7.32 % |
|
5yr Avg Operating Profit Margin
|
17.42 % | 12.95 % | 20.63 % |
|
5 yr average Debt to Equity
|
0.72 | 0.69 | 0.37 |
|
5yr CAGR Net Profit
|
-5.33 % | 27.8 % | n/a |
|
5yr Average Return on Assets
|
5.39 % | 9.54 % | 4.28 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
68.85 % | 50.9 % | 50.01 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 90.41 % |
|
Change in Promoter Holding (3 Yrs)
|
0.08 % | 0.0 | -3.24 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
2.58 % | 8.98 % | -1.36 % |
|
Hikal
|
Innova Captab
|
Shilpa Medicare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|
